DHFR and acute lymphoblastic leukemia: Moreover, particular haplotypes in the promoter of DHFR have been previously found useful in predicting outcome in ALL children under Dana-Farber Cancer Institute (DFCI) ALL Consortium protocol ([27,67] and more recently in AIEOP-protocol [26].